SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

9807	Companies
196783	Keywords
127785	Articles
104617	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 06/03/2024 at 22:15, 1 year 8 months ago

Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3
Sarclisa in combo with VRd significantly enhances progression-free survival in newly diagnosed transplant-ineligible multiple myeloma in phase 3 study at ASCO. Full data published in NEJM

Multiple Myeloma Phase 3 Sarclisa Progression-free Survival VRd
BRIEF

published on 05/31/2024 at 12:05, 1 year 8 months ago

Sanofi Launches 2024 Global Employee Stock Purchase Plan

Financial Investment Sanofi Employee Stock Purchase Plan Action 2024 Global Participation
BRIEF

published on 05/31/2024 at 12:05, 1 year 8 months ago

Sanofi lance un plan mondial d'achat d'actions pour les salariés en 2024

Investissement Financier Sanofi Plan D'achat D'actions Pour Les Salariés Actions 2024 Participation Mondiale
PRESS RELEASE

published on 05/31/2024 at 12:00, 1 year 8 months ago

Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
Sanofi launches 2024 global Employee Stock Purchase Plan, Action 2024, offering discounted shares to 80,000 employees in 56 countries. CEO Paul Hudson affirms commitment to employee participation and company growth

Company Growth Sanofi Employee Stock Purchase Plan Action 2024 Employee Shareholders
PRESS RELEASE

published on 05/31/2024 at 12:00, 1 year 8 months ago

Communiqué de presse : Sanofi lance son plan mondial 2024 d’actionnariat salarié
Sanofi lance son plan mondial 2024 d'actionnariat salarié, ouvert à 80 000 salariés dans 56 pays, offrant actions à 72,87 € avec décote de 20%. Conditions et dates clés précisées pour la souscription

Actionnariat Salarié Souscription Sanofi Plan 2024 Entreprise De Santé
BRIEF

published on 05/31/2024 at 07:10, 1 year 8 months ago

Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO

Sanofi BPCO Dupixent CHMP Approvisionnement
BRIEF

published on 05/31/2024 at 07:10, 1 year 8 months ago

CHMP recommends approval of Dupixent in the EU for the treatment of patients with COPD

Sanofi COPD Dupixent CHMP Supply
PRESS RELEASE

published on 05/31/2024 at 07:05, 1 year 8 months ago

Communiqué de presse : Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO
Le CHMP recommande l'approbation de Dupixent dans l'UE pour le traitement des patients atteints de BPCO. Dupixent deviendrait la première thérapie ciblée pour la BPCO en Europe

Traitement Approbation BPCO Dupixent CHMP
PRESS RELEASE

published on 05/31/2024 at 07:05, 1 year 8 months ago

Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
European Medicines Agency's CHMP recommends Dupixent for EU approval to treat uncontrolled COPD with raised blood eosinophils. If approved, it would be the first targeted therapy for COPD in the EU

Dupixent CHMP EU Approval COPD Treatment Type 2 Inflammation
BRIEF

published on 05/30/2024 at 15:06, 1 year 8 months ago

Sanofi finalise l’acquisition d’Inhibrx, Inc.

Acquisition Sanofi Maladies Rares Inhibrx SAR447537

Accesswire

Published on 02/05/2026 at 13:30, 31 minutes ago

Nextech3D.ai to Report Q3 2025 Earnings After Market Close on February 18, 2026
Published on 02/05/2026 at 13:30, 31 minutes ago

ESGold Expands Montauban Land Position Following 3D Geological Model Identifying Potential District-Scale Mineralized Corridor
Published on 02/05/2026 at 13:20, 41 minutes ago

Guanajuato Silver Sees Significant Growth in Resources at Valenciana
Published on 02/05/2026 at 13:15, 46 minutes ago

Avino Appoints Linda Broughton to The Board of Directors
Published on 02/05/2026 at 13:00, 1 hour 1 minute ago

urban-gro to Implement 1-for-25 Reverse Stock Split

View all ACCESSWIRE

EQS Group

Published on 02/05/2026 at 13:30, 31 minutes ago

Ascory Bank ends its year of transformation in 2025 with positive results and starts 2026 with a new strategy and a new name
Published on 02/05/2026 at 13:04, 57 minutes ago

EQS-Adhoc: Ascory Bank AG raises earnings forecast for financial year 2025
Published on 02/05/2026 at 12:48, 1 hour 12 minutes ago

Turkiye Garanti Bankasi A.S.: Announcement regarding forward looking statements on the expectations for the year 2026
Published on 02/05/2026 at 12:45, 1 hour 16 minutes ago

R.E.A. Holdings plc: Notification of Major Holdings
Published on 02/05/2026 at 11:47, 2 hours 14 minutes ago

Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE

Les Echos

Published on 02/05/2026 at 11:30, 2 hours 31 minutes ago

Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 2 hours 31 minutes ago

Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 19 hours 57 minutes ago

Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 19 hours 57 minutes ago

Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 20 hours 16 minutes ago

Information concerning the total number of voting rights and shares 2026 01 31

View all LES ECHOS COMFI WIRE